Anti-RANKL Therapy Prevents Glucocorticoid-Induced Bone Loss and Promotes Muscle Function in a Mouse Model of Duchenne Muscular Dystrophyaursc20dev2024-01-24T07:26:40-05:00

Anti-RANKL Therapy Prevents Glucocorticoid-Induced Bone Loss and Promotes Muscle Function in a Mouse Model of Duchenne Muscular Dystrophy

Author(s): Jayash et al.
Year: 2023
DOI: 10.1007/s00223-023-01116-w
PMID: 37470794
Related Product: 1200A: Isolated Muscle System for Mice
Research Areas: Molecular Biology and Pharmacology
Disease Models: DMD